Laverock Therapeutics raised €7.6M in a Seed round in Jun 2025. The company is based in Stevenage, UK. Investors in the round: Calculus Capital, Eli lilly and company, Eos Advisory and 3 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.